Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumors.

Koning, C C E; Blank, L E C M; Koedooder, C; van Os, R M; van de Kar, M; Jansen, E; Battermann, J J; Beijert, M; Gernaat, C; van Herpen, K A M; Hoekstra, C; Horenblas, S; Jobsen, J J; Krol, A D G; Lybeert, M L M; van Onna, I E W; Pelger, R C M; Poortmans, P; Pos, F J; van der Steen-Banasik, E; Slot, A; Visser, A; Pieters, B R

Koning, C C E; Blank, L E C M; Koedooder, C; van Os, R M; van de Kar, M; Jansen, E; Battermann, J J; Beijert, M; Gernaat, C; van Herpen, K A M; Hoekstra, C; Horenblas, S; Jobsen, J J; Krol, A D G; Lybeert, M L M; van Onna, I E W; Pelger, R C M; Poortmans, P; Pos, F J; van der Steen-Banasik, E; Slot, A; Visser, A; Pieters, B R.

Affiliation

Koning CCE; Department of Radiation Oncology, Academic Medical Centre (AMC), University of Amsterdam, Amsterdam. Electronic address: c.c.koning@amc.uva.nl.
Blank LECM; Department of Radiation Oncology, Academic Medical Centre (AMC), University of Amsterdam, Amsterdam.
Koedooder C; Department of Radiation Oncology, Academic Medical Centre (AMC), University of Amsterdam, Amsterdam.
van Os RM; Department of Radiation Oncology, Academic Medical Centre (AMC), University of Amsterdam, Amsterdam.
van de Kar M; Department of Radiation Oncology, Academic Medical Centre (AMC), University of Amsterdam, Amsterdam.
Jansen E; Department of Radiation Oncology, Academic Medical Centre (AMC), University of Amsterdam, Amsterdam.
Battermann JJ; Departments of Radiation Oncology and Urology, University Medical Centre Utrecht, Utrecht.
Beijert M; Department of Radiation Oncology, University Medical Centre Groningen, Groningen.
Gernaat C; Department of Radiation Oncology, Medisch Spectrum Twente, Enschede.
van Herpen KAM; TweeSteden Hospital, Department of Urology, Tilburg.
Hoekstra C; Radiotherapeutic Institute RISO, Department of Radiation Oncology, Deventer.
Horenblas S; The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Departments of Urology and Radiation Oncology, Amsterdam.
Jobsen JJ; Department of Radiation Oncology, Medisch Spectrum Twente, Enschede.
Krol ADG; Department of Radiation Oncology, University Medical Centre Leiden, Leiden.
Lybeert MLM; Department of Radiation Oncology, Catharina Hospital Eindhoven.
van Onna IEW; Amphia Hospital, Department of Urology, Breda.
Pelger RCM; Department of Urology, University Medical Centre Leiden, Leiden.
Poortmans P; Institute Verbeeten, Department of Radiation Oncology, Tilburg.
Pos FJ; The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Departments of Urology and Radiation Oncology, Amsterdam.
van der Steen-Banasik E; Arnhem Radiotherapeutic Institute (ARTI), Arnhem.
Slot A; Radiotherapeutic Institute Friesland (RIF), Leeuwarden, The Netherlands.
Visser A; Arnhem Radiotherapeutic Institute (ARTI), Arnhem.
Pieters BR; Department of Radiation Oncology, Academic Medical Centre (AMC), University of Amsterdam, Amsterdam.

Ann Oncol ; 23(11): 2948-2953, 2012 Nov.

Article de En | MEDLINE | ID: mdl-22718135

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la vessie urinaire / Curiethérapie Type d'étude: Observational_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2012 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google